Oct 2026· Nature Communications· Vol 17· 0 citations· 91 references
Medicine
TL;DR
This study identifies DCAF7 as a new regulator of blood stem cells showing how it controls chromatin to preserve stem cell function with implications for understanding normal and malignant blood formation.
Abstract
DCAF7 is one of the few DCAFs expressed in hematopoietic stem cells (HSCs). Using a conditional knockout mouse model, we discovered that the absence of DCAF7 leads to accumulation of differentiating progenitors in the bone marrow, and impairs self-renewal capacity of HSCs upon transplantation. Furthermore, loss of Dcaf7 accelerates the differentiation of HSCs into the myeloid lineage. At the molecular level, DCAF7 interacts with components of the polycomb repressive complex 1 (PRC1) and promotes their assembly into large macromolecular complexes. Chromatin profiling revealed that loss of DCAF7 leads to increased localization of RING1B at transcriptionally active genomic loci. This increased binding was observed at genes involved in myeloid differentiation and was associated with increased mRNA expression. Lastly, inhibition of KDM2/7 proteins rescues the defective growth of Dcaf7 null HSCs in vitro. Together, these data reveal that DCAF7 is a novel regulator of the PRC1 complex and epigenetic enzymes that control HSC differentiation. This study identifies DCAF7 as a new regulator of blood stem cells showing how it controls chromatin to preserve stem cell function with implications for understanding normal and malignant blood formation.
It is found that in adult human HSPC, BRD9 regulates the differentiation of myeloid progenitors, and loss of BRD9 results in increased cBAF recruitment to CEBPA target sites and enhanced myeloid differentiation.
Emmalee R. Adelman, Adedamola A. Adele, Caio Ricardo Gutierrez Silva et al.· bioRxiv· 0 citations
Ex vivo expansion of hematopoietic stem cells (HSCs) is limited by culture-induced oxidative stress, yet the upstream transcriptional drivers remain poorly defined. Here, we show that the transcription factor Bcl11a is rapidly and persistently downregulated during HSC culture and that this decline drives functional det...
Xiang Xu, Lin-Lin Zhang, Yan-Dong An et al.· Journal of Experimental Medi...· 0 citations
INTRODUCTION
CMTM6 is known to stabilize PD-L1 on cancer cells, facilitating immune evasion, but its role in normal hematopoiesis remains unexplored. Hematopoietic stem cell (HSC) homeostasis is tightly regulated by interferon (IFN) signaling, yet the mechanisms controlling IFN receptor stability are unclear.
OBJECTI...
Huan-Di Qiu, Wei He, Yun-Lu Feng et al.· Journal of Advanced Research· 0 citations
ABSTRACT Ribosome biogenesis is crucial for meeting the elevated biosynthetic demands of rapidly expanding fetal hematopoietic stem and progenitor cells (HSPCs) during fetal development. Ddx21 is a DEAD‐box RNA helicase required for ribosome biogenesis, but its role in fetal hematopoiesis remains undefined. Here, we sh...
Adrian On Wah Leung, Chang Li, Xian-Yin Huang et al.· Advancement of science· 0 citations
Abstract Differentiation of stem cells is driven by tightly coordinated transcriptional programs, yet the contribution of circular RNAs (circRNAs) to lineage specification remains poorly defined. Here, we profiled circRNA and messenger RNA expression during differentiation of human embryonic stem cells into five germ l...
Stuart Webb, Vanessa M. Conn, E. V. van Battum et al.· Nucleic Acids Research· 0 citations